Literature DB >> 24374343

Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.

Hui Wang1, Bin Wang2, Qing Liao2, Hongying An2, Weidong Li1, Xuejun Jin1, Shuzhong Cui3, Liang Zhao4.   

Abstract

RhoGDI (Rho GDP-dissociation inhibitor alpha, or RhoGDIα) was identified as a regulator of Rho GTPases, but its role in cancer remains controversial. In this study, increased expression of RhoGDI was detected in hepatocellular carcinoma (HCC) cell lines and tissues with highly metastatic potential. RhoGDI overexpression correlated with postoperative distant metastasis. Enforced expression of RhoGDI in HCC cells significantly enhanced cell proliferation and migration. Conversely, knockdown of RhoGDI caused an inhibition of the aggressive phenotypes of HCC cells. Furthermore, RhoGDI up-regulated Rho, but not Rac, and enhanced PI3K/AKT and MAPK pathway activity. Our findings suggest that RhoGDI overexpression is a predictor of distant metastasis and plays an important role in the progression of HCC.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Neoplasm metastasis; Rho GDP-dissociation inhibitor alpha; Signal transduction

Mesh:

Substances:

Year:  2013        PMID: 24374343     DOI: 10.1016/j.febslet.2013.12.016

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Effects of isoprenylcysteine carboxyl methyltransferase silencing on the proliferation and apoptosis of tongue squamous cell carcinoma.

Authors:  Shao-Ru Wang; Wei Sun; Nan Zhou; Kai Zhao; Wen-Jian Li; Zeng-Peng Chi; Ying Wang; Qi-Min Wang; Lei Tong; Zong-Xuan He; Hong-Yu Han; Zheng-Gang Chen
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation.

Authors:  Ming-Chun Lai; Qian-Qian Zhu; Kwabena-Gyabaah Owusu-Ansah; Yang-Bo Zhu; Zhe Yang; Hai-Yang Xie; Lin Zhou; Li-Ming Wu; Shu-Sen Zheng
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

Review 3.  p53 regulates cytoskeleton remodeling to suppress tumor progression.

Authors:  Keigo Araki; Takahiro Ebata; Alvin Kunyao Guo; Kei Tobiume; Steven John Wolf; Keiko Kawauchi
Journal:  Cell Mol Life Sci       Date:  2015-07-24       Impact factor: 9.261

4.  A direct interaction between RhoGDIα/Tau alleviates hyperphosphorylation of Tau in Alzheimer's disease and vascular dementia.

Authors:  Heping Zhang; Fan Lu; Panhong Liu; Zhaohui Qiu; Jianling Li; Xiaotong Wang; Hui Xu; Yandong Zhao; Xuemin Li; Huadong Wang; Daxiang Lu; Renbin Qi
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-26       Impact factor: 4.147

5.  RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells.

Authors:  Fan Wu; Peishan Hu; Dengke Li; Yan Hu; Yingjiao Qi; Bin Yin; Tao Jiang; Jiangang Yuan; Wei Han; Xiaozhong Peng
Journal:  Oncotarget       Date:  2016-09-20

6.  NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein.

Authors:  Junlan Zhu; Yang Li; Caiyi Chen; Jiugao Ma; Wenrui Sun; Zhongxian Tian; Jingxia Li; Jiheng Xu; Claire S Liu; Dongyun Zhang; Chuanshu Huang; Haishan Huang
Journal:  Neoplasia       Date:  2017-08-01       Impact factor: 5.715

7.  Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.

Authors:  Dandan Huang; Weisi Lu; Shaomin Zou; Huaiming Wang; Yuanling Jiang; Xiya Zhang; Pengqing Li; Zhou Songyang; Lei Wang; Jianping Wang; Junjiu Huang; Lekun Fang
Journal:  Cancer Sci       Date:  2017-05-31       Impact factor: 6.716

8.  Antitumor and antimetastatic activities of a novel benzothiazole-2-thiol derivative in a murine model of breast cancer.

Authors:  XiaoLin Hu; Sen Li; Yan He; Ping Ai; Shaoyong Wu; Yonglin Su; Xiaolin Li; Lei Cai; Xingchen Peng
Journal:  Oncotarget       Date:  2017-02-14

9.  Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.

Authors:  Wei Song; Wei Li; Lingyu Li; Shilin Zhang; Xu Yan; Xue Wen; Xiaoying Zhang; Huimin Tian; Ailing Li; Ji-Fan Hu; Jiuwei Cui
Journal:  Oncotarget       Date:  2015-09-15

10.  RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.

Authors:  William P Bozza; Yaqin Zhang; Kory Hallett; Leslie A Rivera Rosado; Baolin Zhang
Journal:  Oncotarget       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.